A Clinical Study to Evaluate the Pigmentation Reduction Potential of The Derma Co 5 percent Glycolic plus 2 percent Kojic Pigmentation Corrector Ampoule Kit on Healthy Human Subjects - NI

Honasa Consumer Limited0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年7月22日

试验速览

暂无简介。

•1.Gender: Male or Female with age 18-50, with male:female (80:20) ratio with normal , oily (avoid acne and too much oily skin) and combination skin. 3 to 4 candidates with Sensitive skin.
•2. Subjects willing to give written informed consent
•3. Women of child bearing potential must have a negative urine pregnancy test prior to study entry.
•4. Are free of any systemic or dermatologic disorder, which, in the opinion of the investigator, will interfere with the study results or increase the risk of adverse events.
•5. Are willing to avoid prolonged exposure of the treatment area to ultraviolet radiation (natural or artificial) for the duration of the study.
•6. Should be able to read and write (in English, Hindi or local language).
•7. Having valid proof of identity and age.

•1. Pregnant or nursing mothers
•2.Scars, excessive terminal hair or tattoo on the studied area
•3.Hypersensitivity, allergy antecedent (to any cosmetic product, raw material or hair dye)
•4.Any clinically significant systemic or cutaneous disease, which may interfere with study treatment or procedures
•5.Subjects on any medical treatment either systemic or topical which may interfere with the performance of the study treatment (presently or in the past 1 month)
•6.Subject in an exclusion period or participating in another food, cosmetic or therapeutic trial.

发起方

Honasa Consumer Limited